Abstract:Long-lasting, controlled-release, and minimally invasive injectable platforms that provide a stable blood concentration to promote bone regeneration are less well developed. Using hexagonal mesoporous silica (HMS) loaded with dexamethasone (DEX) and poly(lactic-co-glycolic acid) (PLGA), we prepared porous DEX/HMS/PLGA microspheres (PDHP). In contrast to HMS/PLGA microspheres (HP), porous HMS/PLGA microspheres (PHP), DEX/PLGA microspheres (DP), and DEX/HMS/PLGA microspheres (DHP), PDHP showed notable immuno-coordinated osteogenic capabilities and were best at promoting bone mesenchymal stem cell proliferation and osteogenic differentiation. PDHP were combined with methacrylated silk (SilMA) and sodium alginate (SA) to form an injectable photocurable dual-network hydrogel platform that could continuously release the drug for more than 4 months. By adjusting the content of the microspheres in the hydrogel, a zero-order release hydrogel platform was obtained in vitro for 48 days. When the microsphere content was 1%, the hydrogel platform exhibited the best biocompatibility and osteogenic effects. The expression levels of the osteogenic gene alkaline phosphatases, BMP-2 and OPN were 10 to 15 times higher in the 1% group than in the 0% group, respectively. In addition, the 1% microsphere hydrogel strongly stimulated macrophage polarization to the M2 phenotype, establishing an immunological milieu that supports bone regrowth. The aforementioned outcomes were also observed in vivo. The most successful method for correcting cranial bone abnormalities in SD rats was to use a hydrogel called SilMA/SA containing 1% drug-loaded porous microspheres (PDHP/SS). The angiogenic and osteogenic effects of this treatment were also noticeably greater in the PDHP/SS group than in the control and blank groups. In addition, PDHP/SS polarized M2 macrophages and suppressed M1 macrophages in vivo, which reduced the local immune-inflammatory response, promoted angiogenesis, and cooperatively aided in situ bone healing. This work highlights the potential application of an advanced hydrogel platform for long-term, on-demand, controlled release for bone tissue engineering.

Preparation and in Vitro Characterization of Dexamethasone-Loaded Poly(d,l-Lactic Acid) Microspheres Embedded in Poly(ethylene Glycol)–poly(ɛ-Caprolactone)–poly(ethylene Glycol) Hydrogel for Orthopedic Tissue Engineering

Dexamethasone-loaded Poly(d, L-lactic Acid) Microspheres/poly(ethylene Glycol)-Poly(epsilon-caprolactone)-poly(ethylene Glycol) Micelles Composite for Skin Augmentation.

Dual Delivery for Stem Cell Differentiation Using Dexamethasone and Bfgf In/on Polymeric Microspheres As a Cell Carrier for Nucleus Pulposus Regeneration

Covalently Crosslinked Hyaluronic Acid‐chitosan Hydrogel Containing Dexamethasone As an Injectable Scaffold for Soft Tissue Engineering

Electrophoretic Deposition of Dexamethasone-Loaded Mesoporous Silica Nanoparticles Onto Poly(L-Lactic Acid)/Poly(ε-Caprolactone) Composite Scaffold for Bone Tissue Engineering.

Dexamethasone Long-Term Controlled Release from Injectable Dual-Network Hydrogels with Porous Microspheres Immunomodulation Promotes Bone Regeneration

PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis

Biodegradable Hyaluronic Acid Hydrogels to Control Release of Dexamethasone Through Aqueous Diels-Alder Chemistry for Adipose Tissue Engineering

Performance of an in Situ Formed Bioactive Hydrogel Dressing from a PEG-based Hyperbranched Multifunctional Copolymer.

OPTIMIZATION OF PREPARATION OF DEXAMETHASONE ACETATE-LOADED POLY(D,L-LACTIDE) MICROSPHERES BY CENTRAL COMPOSITE DESIGN

Dexamethasone release from hyaluronic acid microparticle and proanthocyanidin-gelatin hydrogel in sciatic tissue regeneration

Fabrication and Characterization of Poly-D-l-lactide/nano-hydroxyapatite Composite Scaffolds with Poly (ethylene Glycol) Coating and Dexamethasone Releasing

Synthesis, physicochemical, rheological and in-vitro characterization of double-crosslinked hyaluronic acid hydrogels containing dexamethasone and PLGA/dexamethasone nanoparticles as hybrid systems for specific medical applications

Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres

Preparation of Polystyrene Microspheres/Peg-Pcl-Peg Hydrogel Composite for Soft Tissue Augmentation

Preparation and Properties of an Injectable Scaffold of Poly(Lactic-Co-Glycolic Acid) Microparticles/Chitosan Hydrogel

Controlled Release of Dexamethasone from Porous PLGA Scaffolds under Cyclic Loading

Preparation of PLGA Microspheres Using the Non-Toxic Glycofurol as Polymer Solvent by a Modified Phase Inversion Methodology

Mechanical Properties and in Vitro Evaluation of Bioactivity and Degradation of Dexamethasone-Releasing Poly-D-l-lactide/nano-hydroxyapatite Composite Scaffolds

An Injectable Thermosensitive Hydrogel Containing Resveratrol and Dexamethasone‐Loaded Carbonated Hydroxyapatite Microspheres for the Regeneration of Osteoporotic Bone Defects

Fabrication of a Layered Microstructured Polymeric Microspheres as a Cell Carrier for Nucleus Pulposus Regeneration.